Insufficient scRNA-seq data for expression of MOS at single-cell level.
Insufficient scRNA-seq data for expression of MOS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 26% | 1.98 | 690 / 2642 | 0% | 0.00 | 1 / 705 |
ovary | 4% | 0.17 | 7 / 180 | 0% | 0.01 | 2 / 430 |
stomach | 2% | 0.08 | 7 / 359 | 0% | 0.00 | 1 / 286 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
esophagus | 1% | 0.05 | 14 / 1445 | 1% | 0.01 | 1 / 183 |
spleen | 1% | 0.04 | 3 / 241 | 0% | 0 | 0 / 0 |
uterus | 1% | 0.02 | 1 / 170 | 1% | 0.02 | 3 / 459 |
intestine | 1% | 0.06 | 10 / 966 | 0% | 0.02 | 1 / 527 |
pancreas | 1% | 0.06 | 4 / 328 | 0% | 0 | 0 / 178 |
breast | 1% | 0.05 | 5 / 459 | 0% | 0.00 | 1 / 1118 |
kidney | 1% | 0.07 | 1 / 89 | 0% | 0 | 0 / 901 |
liver | 0% | 0 | 0 / 226 | 1% | 0.08 | 4 / 406 |
lung | 1% | 0.02 | 3 / 578 | 0% | 0.01 | 5 / 1155 |
prostate | 1% | 0.03 | 2 / 245 | 0% | 0 | 0 / 502 |
peripheral blood | 1% | 0.03 | 6 / 929 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.02 | 2 / 653 | 0% | 0.01 | 2 / 605 |
adipose | 0% | 0.02 | 6 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.02 | 4 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.01 | 1 / 230 |
skin | 0% | 0.01 | 5 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 0% | 0.01 | 3 / 1335 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.00 | 1 / 504 |
heart | 0% | 0.00 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0000165 | Biological process | MAPK cascade |
GO_0007165 | Biological process | signal transduction |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0051296 | Biological process | establishment of meiotic spindle orientation |
GO_0001556 | Biological process | oocyte maturation |
GO_0000212 | Biological process | meiotic spindle organization |
GO_1902103 | Biological process | negative regulation of metaphase/anaphase transition of meiotic cell cycle |
GO_0040020 | Biological process | regulation of meiotic nuclear division |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MOS |
Protein name | Proto-oncogene serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos) (Proto-oncogene c-Mos) |
Synonyms | |
Description | FUNCTION: Serine/threonine kinase involved in the regulation of MAPK signaling. Is an activator of the ERK1/2 signaling cascade playing an essential role in the stimulation of oocyte maturation. . |
Accessions | P00540 ENST00000311923.1 |